1. Home
  2. KFRC vs COLL Comparison

KFRC vs COLL Comparison

Compare KFRC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KFRC
  • COLL
  • Stock Information
  • Founded
  • KFRC 1962
  • COLL 2002
  • Country
  • KFRC United States
  • COLL United States
  • Employees
  • KFRC N/A
  • COLL N/A
  • Industry
  • KFRC Professional Services
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KFRC Consumer Discretionary
  • COLL Health Care
  • Exchange
  • KFRC Nasdaq
  • COLL Nasdaq
  • Market Cap
  • KFRC 1.1B
  • COLL 1.1B
  • IPO Year
  • KFRC 1995
  • COLL 2015
  • Fundamental
  • Price
  • KFRC $56.86
  • COLL $33.19
  • Analyst Decision
  • KFRC Buy
  • COLL Strong Buy
  • Analyst Count
  • KFRC 3
  • COLL 5
  • Target Price
  • KFRC $66.67
  • COLL $43.80
  • AVG Volume (30 Days)
  • KFRC 82.0K
  • COLL 486.5K
  • Earning Date
  • KFRC 02-03-2025
  • COLL 02-20-2025
  • Dividend Yield
  • KFRC 2.67%
  • COLL N/A
  • EPS Growth
  • KFRC 9.19
  • COLL 757.11
  • EPS
  • KFRC 2.90
  • COLL 2.16
  • Revenue
  • KFRC $1,424,973,000.00
  • COLL $599,245,000.00
  • Revenue This Year
  • KFRC N/A
  • COLL $13.20
  • Revenue Next Year
  • KFRC $0.84
  • COLL $17.63
  • P/E Ratio
  • KFRC $19.62
  • COLL $15.37
  • Revenue Growth
  • KFRC N/A
  • COLL 9.62
  • 52 Week Low
  • KFRC $52.96
  • COLL $28.39
  • 52 Week High
  • KFRC $74.79
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • KFRC 50.38
  • COLL 61.14
  • Support Level
  • KFRC $55.73
  • COLL $32.29
  • Resistance Level
  • KFRC $57.60
  • COLL $33.99
  • Average True Range (ATR)
  • KFRC 1.28
  • COLL 1.32
  • MACD
  • KFRC 0.21
  • COLL 0.44
  • Stochastic Oscillator
  • KFRC 82.71
  • COLL 84.58

About KFRC Kforce Inc.

Kforce Inc provides professional and technical specialty staffing services and solutions. The company operates two business segments: 1) technology segment where the company provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) FA segment where the company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: